• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者的生活质量与支持性护理需求:新西兰毛利族和非毛利族患者所接受治疗及护理服务利用情况的影响

Quality of life and supportive care needs in prostate cancer: the impact of treatment received and care service utilization among Māori and non-Māori patients in New Zealand.

作者信息

Xiao Hui, Baxter G David, Liu Lizhou, Hoeta Tobias, Wibowo Erik

机构信息

Centre for Men's Health NZ, Centre for Health, Activity and Rehabilitation Research, School of Physiotherapy, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.

Exercise Oncology Lab, Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, Canada.

出版信息

Support Care Cancer. 2025 May 20;33(6):483. doi: 10.1007/s00520-025-09521-7.

DOI:10.1007/s00520-025-09521-7
PMID:40394376
Abstract

BACKGROUND

Prostate cancer treatment can lead to significant long-term side effects that impact patients' quality of life and supportive care needs (SCN). This study explores the associations between quality of life (QoL) and SCN among prostate cancer survivors, with a focus on the impact of treatment received, care service utilization, and the differences between Māori and non-Māori patients.

METHODS

Random stratified sampling data were collected from 1075 prostate cancer survivors who were diagnosed within the past 5 years. Hierarchical regression analyses examined the associations between QoL domains and SCN, adjusting for demographic, clinical, and treatment-related factors. LASSO (Least Absolute Shrinkage and Selection Operator) was used to select variables to test the interaction effects of different treatments.

RESULTS

Significant disparities were found between Māori and non-Māori patients in physical and mental health scores, care service utilization, and overall SCN. Māori men had lower scores in these areas. Most QoL domains were negatively associated with more SCN, particularly mental health and hormonal issues. Androgen deprivation therapy (ADT) exacerbates some negative effects of poor mental health and hormonal issues for non-Māori, while the use of care services and radical prostatectomy (RP) was associated with mitigating SCN for Māori patients.

CONCLUSION

This study highlights the complex interplay between QoL, SCN, and treatment modalities among prostate cancer survivors in New Zealand. The findings underscore the need for culturally tailored supportive care services to address the unique needs of Māori patients.

摘要

背景

前列腺癌治疗可导致严重的长期副作用,影响患者的生活质量和支持性护理需求(SCN)。本研究探讨前列腺癌幸存者的生活质量(QoL)与SCN之间的关联,重点关注所接受治疗的影响、护理服务利用情况以及毛利族和非毛利族患者之间的差异。

方法

从过去5年内确诊的1075名前列腺癌幸存者中收集随机分层抽样数据。分层回归分析检验了生活质量领域与SCN之间的关联,并对人口统计学、临床和治疗相关因素进行了调整。使用最小绝对收缩和选择算子(LASSO)选择变量,以测试不同治疗的交互作用。

结果

毛利族和非毛利族患者在身心健康评分、护理服务利用情况和总体SCN方面存在显著差异。毛利族男性在这些方面得分较低。大多数生活质量领域与更多的SCN呈负相关,尤其是心理健康和激素问题。雄激素剥夺疗法(ADT)加剧了非毛利族心理健康不佳和激素问题的一些负面影响,而使用护理服务和根治性前列腺切除术(RP)与减轻毛利族患者的SCN相关。

结论

本研究强调了新西兰前列腺癌幸存者的生活质量、SCN和治疗方式之间的复杂相互作用。研究结果强调需要提供符合文化特点的支持性护理服务,以满足毛利族患者的独特需求。

相似文献

1
Quality of life and supportive care needs in prostate cancer: the impact of treatment received and care service utilization among Māori and non-Māori patients in New Zealand.前列腺癌患者的生活质量与支持性护理需求:新西兰毛利族和非毛利族患者所接受治疗及护理服务利用情况的影响
Support Care Cancer. 2025 May 20;33(6):483. doi: 10.1007/s00520-025-09521-7.
2
The Landscape of Supportive Care Needs Among Prostate Cancer Patients in New Zealand: A Cross-Ethnic Analysis.新西兰前列腺癌患者支持性护理需求状况:一项跨种族分析。
Psychooncology. 2025 Feb;34(2):e70110. doi: 10.1002/pon.70110.
3
Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.根治性前列腺切除术或观察等待联合或不联合雄激素剥夺治疗后的生活质量:SPCG-4 随机试验。
Eur Urol Oncol. 2018 Jun;1(2):134-142. doi: 10.1016/j.euo.2018.03.003. Epub 2018 May 15.
4
Experiences of Unmet Need and Access to Supportive Care for Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Bi-national Study.接受雄激素剥夺疗法治疗前列腺癌的男性的未满足需求和获得支持性护理的体验:一项跨国研究。
Semin Oncol Nurs. 2020 Aug;36(4):151049. doi: 10.1016/j.soncn.2020.151049. Epub 2020 Jul 21.
5
Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.评估肌肉和非肌肉浸润性膀胱癌患者在疾病轨迹中的生活质量、信息和支持性护理需求。
Support Care Cancer. 2019 Oct;27(10):3877-3885. doi: 10.1007/s00520-019-4649-z. Epub 2019 Feb 14.
6
Effects of a culturally tailored patient navigation program on unmet supportive care needs in Hispanic/Latino cancer survivors: A randomized controlled trial.一项针对西班牙裔/拉丁裔癌症幸存者未满足的支持性护理需求的文化定制患者导航计划的效果:一项随机对照试验。
Cancer. 2025 Jan 1;131(1):e35626. doi: 10.1002/cncr.35626. Epub 2024 Nov 1.
7
Inequalities between Māori and non-Māori men with prostate cancer in Aotearoa New Zealand.新西兰奥特亚罗瓦地区患前列腺癌的毛利男性与非毛利男性之间的不平等现象。
N Z Med J. 2020 Sep 4;133(1521):69-76.
8
Treatment modalities for Māori and New Zealand European men with localised prostate cancer.针对患有局限性前列腺癌的毛利族和新西兰欧洲族男性的治疗方式。
Int J Clin Oncol. 2015 Aug;20(4):814-20. doi: 10.1007/s10147-014-0781-4. Epub 2015 Jan 6.
9
Maori men's perceptions and experiences of health seeking for prostate health problems in New Zealand.新西兰毛利男性对前列腺健康问题寻求医疗服务的认知与经历。
Pac Health Dialog. 2003 Sep;10(2):71-8.
10
Survival disparities between Māori and non-Māori men with prostate cancer in New Zealand.新西兰毛利族与非毛利族前列腺癌男性患者的生存差异。
BJU Int. 2015 Apr;115 Suppl 5:24-30. doi: 10.1111/bju.12900.

引用本文的文献

1
Transcriptomic and functional analysis of triphenyl phosphate exposure in prostate cancer progression.三苯基磷酸酯暴露在前列腺癌进展中的转录组学和功能分析。
Discov Oncol. 2025 Aug 7;16(1):1497. doi: 10.1007/s12672-025-03325-1.

本文引用的文献

1
The Landscape of Supportive Care Needs Among Prostate Cancer Patients in New Zealand: A Cross-Ethnic Analysis.新西兰前列腺癌患者支持性护理需求状况:一项跨种族分析。
Psychooncology. 2025 Feb;34(2):e70110. doi: 10.1002/pon.70110.
2
'Survivorship care is one big gap': a qualitative study of post-treatment supportive care in Aotearoa New Zealand.“生存护理是一个巨大的缺口”:新西兰治疗后支持性护理的定性研究。
BMC Health Serv Res. 2023 Jun 8;23(1):594. doi: 10.1186/s12913-023-09580-8.
3
Gut environment changes due to androgen deprivation therapy in patients with prostate cancer.
由于前列腺癌患者雄激素剥夺治疗,肠道环境发生改变。
Prostate Cancer Prostatic Dis. 2023 Jun;26(2):323-330. doi: 10.1038/s41391-022-00536-3. Epub 2022 Apr 13.
4
Supportive care needs of men with prostate cancer: A systematic review update.前列腺癌男性患者的支持性照护需求:系统评价更新。
Eur J Cancer Care (Engl). 2022 Mar;31(2):e13541. doi: 10.1111/ecc.13541. Epub 2022 Jan 17.
5
Prostate cancer outcomes disparities: Population survival analysis in an ethnically diverse nation.前列腺癌结局差异:一个种族多元化国家的人群生存分析
Urol Oncol. 2021 Jun;39(6):367.e19-367.e26. doi: 10.1016/j.urolonc.2021.02.023. Epub 2021 Apr 12.
6
Inequalities between Māori and non-Māori men with prostate cancer in Aotearoa New Zealand.新西兰奥特亚罗瓦地区患前列腺癌的毛利男性与非毛利男性之间的不平等现象。
N Z Med J. 2020 Sep 4;133(1521):69-76.
7
Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life After Treatment for Localized Prostate Cancer.扩展前列腺癌指数综合量表-26(EPIC-26)在线版:一种基于互联网的工具用于评估局限性前列腺癌治疗后健康相关生活质量的验证
Urology. 2019 May;127:53-60. doi: 10.1016/j.urology.2019.02.004. Epub 2019 Feb 18.
8
Health service provider responses to indigenous peoples with cancer: An integrative review.医疗服务提供者对患癌原住民的应对措施:一项综合综述。
Eur J Cancer Care (Engl). 2019 Mar;28(2):e12975. doi: 10.1111/ecc.12975. Epub 2018 Dec 9.
9
Quality of life in men with metastatic prostate cancer in their final years before death - a retrospective analysis of prospective data.在死亡前最后几年患有转移性前列腺癌的男性的生活质量 - 前瞻性数据的回顾性分析。
BMC Palliat Care. 2018 Dec 3;17(1):126. doi: 10.1186/s12904-018-0381-6.
10
Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer.前列腺癌男性雄激素剥夺治疗相关的主要长期副作用风险。
Pharmacotherapy. 2018 Oct;38(10):999-1009. doi: 10.1002/phar.2168. Epub 2018 Sep 4.